4.7 Review

Nano-Medicine in the Cardiovascular System

期刊

FRONTIERS IN PHARMACOLOGY
卷 12, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2021.640182

关键词

cardiac nano-medicine; therapeutic nanoparticles; diagnostic nanoparticles; regenerative exosomes; cardio-protective nanoparticles

资金

  1. National Institutes of Health (NIH) through NHLBI [RO1 HL95077, HL114120, HL131017, HL149137]

向作者/读者索取更多资源

Nano-medicines, including nanoparticles, nanocomposites, small molecules, and exosomes, offer promising future therapies for cardiovascular system dysfunction and other organ disorders due to their special physicochemical properties and favorable cellular responses. The success of these nano-medicines in cardiovascular theranostic applications relies on a comprehensive understanding of the intersection between nanomaterials and biomedical fields. Current research in cardiac nano-medicines focuses on exploring the diverse nature of nanomaterials and their applications, while addressing concerns such as cellular responses, toxicity, and cardio-protective and regenerative capabilities.
Nano-medicines that include nanoparticles, nanocomposites, small molecules, and exosomes represent new viable sources for future therapies for the dysfunction of cardiovascular system, as well as the other important organ systems. Nanomaterials possess special properties ranging from their intrinsic physicochemical properties, surface energy and surface topographies which can illicit advantageous cellular responses within the cardiovascular system, making them exceptionally valuable in future clinical translation applications. The success of nano-medicines as future cardiovascular theranostic agents requires a comprehensive understanding of the intersection between nanomaterial and the biomedical fields. In this review, we highlight some of the major types of nano-medicine systems that are currently being explored in the cardiac field. This review focusses on the major differences between the systems, and how these differences affect the specific therapeutic or diagnostic applications. The important concerns relevant to cardiac nano-medicines, including cellular responses, toxicity of the different nanomaterials, as well as cardio-protective and regenerative capabilities are discussed. In this review an overview of the current development of nano-medicines specific to the cardiac field is provided, discussing the diverse nature and applications of nanomaterials as therapeutic and diagnostic agents.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据